StockWatch
·
HomeLiveReports

Cardiff Oncology, Inc.

Ticker: 1213037

OverviewP/LShare Hold
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-18.27-5.776.7319.23Q3 FY23Q1 FY24Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q2 FY26

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q3 FY23Q1 FY24Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q2 FY26
PeriodQ2 FY26Q3 FY25Q2 FY25Q1 FY25Q3 FY24Q2 FY24Q1 FY24Q3 FY23
INCOME
Revenue0.10-16.7%0.12+0.0%0.12+9.1%0.11-35.3%0.17+6.3%0.16-23.8%0.21+50.0%0.14
Total Income0.10-16.7%0.12+0.0%0.12+9.1%0.11-35.3%0.17+6.3%0.16-23.8%0.21+50.0%0.14
EXPENSES
Expenditure9.72-19.6%12.09-18.9%14.90+2.8%14.49+13.5%12.77+0.5%12.71+14.1%11.14+1.6%10.96
PROFIT
Net Profit-9.23+18.0%-11.26+19.2%-13.94-3.8%-13.43-13.2%-11.86-0.7%-11.78-17.7%-10.01-2.9%-9.73
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.14+17.6%-0.17+19.0%-0.21-5.0%-0.20+20.0%-0.25+3.8%-0.26-18.2%-0.22+0.0%-0.22

Corporate Events

Board MeetingCRDF
2026
22Oct

Board Meeting

To adopt and approve an amendment to increase the number of …

SEC Filing ↗
Board MeetingCRDF
2026
6Apr

Board Meeting

Josh Muntner appointed Chief Financial Officer, Ajay Aggarwa…

SEC Filing ↗